← brief for 2026-09-30 · Slowing decline

Finerenone versus spironolactone in heart failure with mildly reduced or preserved ejection fraction: a real-world study.

Article C Peer reviewed Observational

Key takeaways

This study compared two heart failure drugs, finerenone and spironolactone, in real-world patients. It looked at who lived longer or had fewer hospital visits over 12 months. Because it is an observational study, it shows a link but not proof of cause. It helps doctors understand how these drugs work in daily practice.

Who did this work

Ha PTK · Chao CJ · Hung CL · Chang HY · Chen CW · Lin YC · Huang CY · Shao YH · Hsu CY

Source

Article · PubMed, the drug frontier · 2026 Sep 30
https://pubmed.ncbi.nlm.nih.gov/42813221/